Mookho Malahleha

机构：University of Cape Town, Synergy Health, Setshaba Research Centre · ORCID：0000-0003-1879-8471

发表论文 54 篇 · 总被引 11452 次 · h-index 22

代表论文

• Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial (2024 · The Lancet Infectious Diseases · 被引 62)
• Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk (2022 · The Journal of Infectious Diseases · 被引 52)
• Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial (2024 · The Lancet Infectious Diseases · 被引 44)
• Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials (2023 · JAMA Network Open · 被引 38)
• Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study (2021 · The Lancet HIV · 被引 32)
• Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa (2023 · PLOS Global Public Health · 被引 19)